Predictors of Prosthetic Eligibility after Major Lower Limb Amputation: A Retrospective Cohort Study
Annals of Vascular Surgery · 2026-07 · 128 · 385-392
DOI: 10.1016/j.avsg.2026.02.052 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Vascular Surgery, 2026-07. Verfasst von Miguel Gomes-Ferreira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Escola de Medicina da Universidade do Minho, Braga, Portugal. Electronic address: gomesmiguel2000@gmail.com. Hauptthemen laut MEDLINE: Amputation, Surgical, Peripheral Arterial Disease, Lower Extremity, Artificial Limbs. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
BACKGROUND Peripheral arterial disease (PAD) and lower-limb ischemia often require major amputation, with profound effects on patients' quality of life and substantial healthcare and social costs. Although prosthetic rehabilitation is complex, it can significantly improve functional autonomy and quality of life. This study aimed to identify clinical, functional, and demographic factors associated with prosthetic eligibility to optimize rehabilitation pathways and streamline prosthesis allocation. METHODS A retrospective observational study was conducted, including 218 patients who underwent major lower-limb amputation between 2020 and 2023. Demographic, clinical, and functional data were collected. Associations with prosthesis prescription or waiting status were analysed using chi-square tests, Mann-Whitney tests, and confirmed by multivariable logistic regression. RESULTS Only 30.7% of patients were deemed eligible for a prosthesis, and 12.8% ultimately received the device. In multivariable analysis, pre-amputation autonomy (OR = 0.222; p = 0.006) and participation in a rehabilitation program (OR = 34.7; p < 0.001) remained independently associated with prosthetic fitting. Younger age, male sex, and transtibial amputation level were positively associated in univariate analysis. CONCLUSION Pre-amputation functional autonomy and access to structured rehabilitation programs are critical determinants of successful prosthetic rehabilitation. Early referral and structured rehabilitation strategies may improve functional outcomes, reduce healthcare costs, and enhance patients' quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Escola de Medicina da Universidade do Minho, Braga, Portugal. Electronic address: gomesmiguel2000@gmail.com.
- Department of Angiology and Vascular Surgery, Health Local Unit of Braga, Braga, Portugal.
- Department of Biomedicine, Unity of Anatomy, Faculty of Medicine of the University of Porto, Portugal; CINTESIS@RISE, Department of Biomedicine, Unity of Anatomy, Faculty of Medicine of the University of Porto, Portugal.
- 1st Chair and Department of General and Vascular Surgery, Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland; Department of General, Vascular and Oncological Surgery, Masovian Brodnowski Hospital, Warsaw,…
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Gomes-Ferreira, M., Marques-Vieira, M., Rocha-Neves, J., Myrcha, P., Marcel-Rodrigues, R., & Oliveira, J. (2026). Predictors of Prosthetic Eligibility after Major Lower Limb Amputation: A Retrospective Cohort Study. Annals of Vascular Surgery, 128, 385-392. https://doi.org/10.1016/j.avsg.2026.02.052
Vancouver
Gomes-Ferreira M, Marques-Vieira M, Rocha-Neves J, Myrcha P, Marcel-Rodrigues R, Oliveira J. Predictors of Prosthetic Eligibility after Major Lower Limb Amputation: A Retrospective Cohort Study. Annals of Vascular Surgery. 2026;128:385-392. doi:10.1016/j.avsg.2026.02.052
BibTeX
@article{GomesFerreira2026,
author = {Gomes-Ferreira, Miguel and Marques-Vieira, Mário and Rocha-Neves, João and Myrcha, Piotr and Marcel-Rodrigues, Roger and Oliveira, João},
title = {Predictors of Prosthetic Eligibility after Major Lower Limb Amputation: A Retrospective Cohort Study},
journal = {Annals of Vascular Surgery},
year = {2026},
volume = {128},
pages = {385--392},
doi = {10.1016/j.avsg.2026.02.052}
}
EUVIMED